Table 1.

Baseline demographics and clinical characteristics of the total enrolled cohort and subset with 2 years follow-up.

	Total (n = 30)	2-year follow-up (n = 23)	2-year monthly follow-up (n = 16)	P value (between total and monthly follow-up)
Age	78.2 ± 6.9	77.9 ± 10.8	78.1 ± 7.0	0.945
Gender, Female (%)	14 (47%)	13 (57%)	8 (50%)	0.829
Baseline BCVA ± SD (logMAR)	0.74 ± 0.40	0.64 ± 0.31	0.62 ± 0.27	0.238
Baseline CMT(µm) ± SD	356.7 ± 132	348.5 ± 122	344.2 ± 135	0.771
Lens status (phakic)	17	14	9	0.978
CNVM Type (classic)	10	7	5	0.886

P < 0.05 is statistically significant.

BCVA best-corrected visual acuity, CMT central macular thickness, CNVM choroidal neovascular membrane.